Innovation Advantage

Collaboration project with Prof. Liu Baolin from University of Shanghai for Science and Technology: Sample Cooling and Rewarming Techniques Applied to Technologies related to Cryopreservation of Active Bio-samples.

With joint project research as the regular cooperation mechanism, a joint scientific research key project team is established to tackle the technology fields such as optimization of cell cooling process, innovative cooling technology, innovative rewarming technology, etc.

Mr. Gao Dayong, chairman of International Society for Cryobiology and professor at University of Washington, USA, is working as chief scientist of cryobiology at Origin Cell, and has established, together with the company, the industry's leading cryogenic bio-freezing technology platform, for the research on the best cryopreservation technology, methods and developing related products.

Prof. Gao Dayong, renowned expert in cryobiology, former chairman of International Society for Cryobiology, tenured professor at University of Washington, USA, in the Mechanical Engineering and Bio-engineering departments, Master Chair (II) professor at University of Science and Technology of China, member of Changjiang Scholars Program of Ministry of Education of China, special term professor at University of Science and Technology of China, and support specialist of Hundred Talents Program of the Chinese Academy of Sciences.

The team of Prof. Liu Baolin, Dean of Medical Device and Food College of University of Shanghai for Science and Technology, and the team of Prof. Fan Xiumin, Deputy Director of Institute of Mechanical Manufacture and Automation, Shanghai Jiaotong University, have been invited, as resident instructors, to promote the Industry-University-Research Cooperation in the fields of domestic cryobiology and intelligent biobank construction.

Application and transformation of the advanced technology exploration and theoretical foundation of colleges and universities have been sought in enterprises and industries, and have made unique contribution to the development of China's emerging cell biomedical industry, combining both economic and social benefits, and are in accordance with the "Healthy Shanghai" planning layout and the key development planning of China's biomedical field.